Article info
PDFPostScript
Letter
Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel disease
- Correspondence to Professor Alexander C Ford, Leeds Gastroenterology Institute, St. James's University Hospital, Leeds LS9 7TF, UK; alexf12399{at}yahoo.com
Citation
Effect of ACE inhibitors and angiotensin II receptor blockers on disease outcomes in inflammatory bowel disease
Publication history
- Received March 22, 2020
- Revised March 25, 2020
- Accepted March 25, 2020
- First published April 2, 2020.
Online issue publication
December 09, 2020
Article Versions
- Previous version (2 April 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.